Rocket One Inc. Selling, General and Administrative Expense
Rocket One Inc. (RKTO) reported Selling, General and Administrative Expense of $237.64 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-08-12
- Rocket One Inc. selling, general and administrative expense for the quarter ending 2022-06-30 was $237.64K, a 8.61% increase year-over-year.
- Rocket One Inc. selling, general and administrative expense for the quarter ending 2021-06-30 was $218.79K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month |
|---|---|---|
| 2022-06-30 | $237.64K 10-Q · filed 2022-08-12 | $450.31K 10-Q · filed 2022-08-12 |
| 2021-06-30 | $218.79K 10-Q · filed 2022-08-12 | $399.69K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |